...
首页> 外文期刊>Journal of Equine Veterinary Science >Methadone Increases and Prolongs Detomidine-Induced Arterial Hypertension in Horses, but These Effects Are Not Mediated by Increased Plasma Concentrations of Arginine Vasopressin or Serum Concentrations of Catecholamines
【24h】

Methadone Increases and Prolongs Detomidine-Induced Arterial Hypertension in Horses, but These Effects Are Not Mediated by Increased Plasma Concentrations of Arginine Vasopressin or Serum Concentrations of Catecholamines

机译:美沙酮增加并延长马的托托咪定诱导的动脉高血压,但这些作用并未通过精氨酸加压素或血浆儿茶酚胺浓度的升高而介导

获取原文
获取原文并翻译 | 示例
           

摘要

Catecholamines and arginine vasopressin (AVP) release can affect arterial blood pressure (ABP) and hemodynamic stability in standing, sedated horses. Six mature horses were included in this prospective, randomized, crossover, blinded, experimental study. All the horses were sedated with detomidine (DET) alone (0.01 mg/kg, IV) or combined with methadone (MET) (0.01 mg/kg DET and 0.2 mg/kg MET, IV). Cardiopulmonary data and blood samples were collected 30 minutes before (prebaseline and baseline) and for 120 minutes postinjection. The combination DET/MET produced a significant increase (31%) in mean ABP (MAP) 5 minutes after drug administration which lasted for 120 minutes. Detomidine alone induced only a short-term increase in MAP (15%) at 5 minutes compared with baseline. There were significant differences between groups at 5, 15, and from 60 to 120 minutes. Plasma AVP concentrations were higher in horses receiving the treatment DET from 60 to 120 minutes than those in the combination group, for the same period. There were no significant differences in norepinephrine and epinephrine serum concentrations respect to baseline and between treatments. Detomidine induces a short-term MAP increase, and this effect was prolonged and potentiated by MET association. There is no evidence of AVP, norepinephrine, and epinephrine involvement in this effect. (C) 2016 Elsevier Inc. All rights reserved.
机译:儿茶酚胺和精氨酸加压素(AVP)的释放可影响站立的镇静马匹的动脉血压(ABP)和血液动力学稳定性。这项前瞻性,随机,交叉,盲法实验研究中包括了六只成熟马。所有马匹均单独用托咪定(DET)(0.01 mg / kg,静脉内)镇静,或与美沙酮(MET)(0.01 mg / kg DET和0.2 mg / kg MET,IV)结合镇静。在注射前30分钟(基线前和基线)和注射后120分钟收集心肺数据和血液样本。药物治疗后5分钟,DET / MET组合的平均ABP(MAP)显着增加(31%),持续120分钟。与基线相比,单独的托咪定仅在5分钟时引起MAP的短期升高(15%)。在第5、15和60至120分钟时,各组之间存在显着差异。在同一时期,接受治疗DET 60至120分钟的马血浆AVP浓度高于联合治疗组的马。相对于基线和治疗之间,去甲肾上腺素和肾上腺素的血清浓度无显着差异。地托米定可引起短期MAP升高,而MET联合可延长并增强这种作用。没有证据表明AVP,去甲肾上腺素和肾上腺素参与了这种作用。 (C)2016 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号